Latest

Aug 11, 2017
Everyone’s talking value, but not everyone is willing to pin down the elusive concept. Pharm Exec talks with Steven Pearson, founder of the Institute for Clinical Effectiveness Review (ICER), about all things value-based.
Aug 09, 2017
Pharmaceutical Executive
Experts assess the current pharma dealmaking landscape—one where, despite market headwinds, is still heavily influenced by factors under the buyer and seller’s control.
Aug 08, 2017
Pharmaceutical Executive
Four strategic takeaways from this year's event that are important for pharma oncology leaders, by Maria Whitman and Sharon Karlsberg.
Aug 05, 2017
Pharmaceutical Executive
For the life sciences industry in 2017, engaging across social media means less talking—and more listening. Peter Houston reports.
Jul 26, 2017
Pharma companies have been protesting expansion of the federal program that provides deeply discounted prescription drugs to certain hospitals and health providers serving low-income, uninsured patients.
Jul 16, 2017
Pharmaceutical Executive
Outlining the four core elements pharma companies need to lay the foundation for a solid digital health infrastructure.
Jul 15, 2017
Mary Ann Slack and Mitra Rocca outline how FDA is adopting electronic practices and initiating efforts to simplify the submission process for new drug and generic drug applications.
Jul 07, 2017
Pharmaceutical Executive
David Keane outlines four best practices in implementing AI-based technology to help achieve physician-engagement wins.
Jun 20, 2017
There is a tremendous, untapped market of undiagnosed patients for a variety of conditions, writes John Pagliuca. But how do you identify them when they are essentially hidden from view through conventional means?
Jun 20, 2017
Most challenges boil down to two simple categories: "complicated" and "complex". Knowing how to categorize each problem is key to solving it, writes Steve Figman.
native1_300x100
lorem ipsum